Kevin A Kelley, PhD
img_Kevin A Kelley
PROFESSOR | Cell, Developmental & Regenerative Biology
The Mouse Genetics Shared Research Facility (SRF) was established in 1999 to provide the faculty of Mount Sinai with a state-of-the-art facility for the production of novel, genetically manipulated mouse lines. The research efforts of this group include microinjection of gene fragments for production of transgenic mice, microinjection of selected ES cells for the production of gene-targeted mouse lines, rederivations of mouse lines for removal of mouse pathogens, and cryopreservation of mouse gametes. In addition to these research goals, the SRF provides investigators with an outstanding resource for aid with transgene design, protocols for ES cell culture, and general assistance with all phases of mouse genetics. In addition to the goals of the SRF, my collaborative research interests using the mouse as a model system span several areas of developmental biology as evidenced by the following publications.

For detailed information, please consult our shared research facility website.

PhD, Johns Hopkins University

Yale University School of Medicine


Irma T. Hirschl Career Scientist Award


Swebilius Cancer Research Award


Postdoctoral Fellow

American Cancer Society

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Kelley did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.